Retraction notice to "Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models" [Life Sci. 288 (2022) 120166]
Life Sci. 2024 Aug 1:350:122775.
doi: 10.1016/j.lfs.2024.122775.
Epub 2024 Jun 8.
1 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
3 Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
4 Nanoparticle Process Technology, Faculty of Engineering, University of Duisburg-Essen, Duisburg, Germany.
5 Department of Cell and Molecular Biology, School of Advanced Sciences, Islamic Azad University, Tehran, Medical Branch, Iran.
6 Department of Biochemistry, Faculty of Materials Engineering, Islamic Azad University, Najafabad Branch, Najafabad, Iran.
7 Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
8 Department of Public Health, Maragheh University of Medical Sciences, Maragheh, Iran.
9 Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
10 Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
11 Immunogenetic Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
12 Bioclinicum, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; Department of Immunology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
13 Department of Basic Science, Faculty of Medicine, Maragheh University of Medical Sciences, Maragheh, Iran.
14 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.